Sandu Pharmaceuticals standalone net profit declines 38.24% in the September 2018 quarter

Sales decline 30.19% to Rs 12.21 crore

Net profit of Sandu Pharmaceuticals declined 38.24% to Rs 0.21 crore in the quarter ended September 2018 as against Rs 0.34 crore during the previous quarter ended September 2017. Sales declined 30.19% to Rs 12.21 crore in the quarter ended September 2018 as against Rs 17.49 crore during the previous quarter ended September 2017. ParticularsQuarter EndedSep. 2018Sep. 2017% Var.Sales12.2117.49 -30 OPM %5.574.69 -PBDT0.470.46 2 PBT0.310.34 -9 NP0.210.34 -38

Powered by Capital Market - Live News